X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript March 21, 2024
X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.15. XFOR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Greetings. And welcome to the X4 Pharmaceuticals Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call. At this time, all participants are in a...
